Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding
Sign Up to like & getrecommendations! Published in 2017 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2016.10.008
Abstract: Programmed cell death–1 receptor (PD-1) inhibitors enhance the antitumoral immune response via immune checkpoint inhibition. In a healthy immune system, the binding of ligands to PD-1 induces T-cell inactivation and prevents overactive immune responses. However,… read more here.
Keywords: like depigmentation; depigmentation patient; patient acute; vitiligo like ... See more keywords